China's TB Portfolio for Advancing the 2030 End TB Goals

Area of Science:

• Public Health and Epidemiology
• Infectious Disease Control

Background:

• Global tuberculosis (TB) elimination progress is precarious, failing to meet 2025 targets and threatened by funding cuts.
• The coronavirus disease 2019 (COVID-19) pandemic has further disrupted TB control efforts worldwide.
• China, however, has achieved a significant TB incidence reduction, transitioning towards a lower-incidence setting.

Purpose of the Study:

• To describe China's national and provincial TB incidence-reduction targets for 2025 and 2030.
• To outline China's comprehensive TB control program across the continuum of care.
• To present China's integrated strategy as a potential blueprint for low- and middle-income countries.

Main Methods:

• Review of China's national and provincial TB incidence-reduction targets.
• Analysis of China's comprehensive TB control program components.
• Examination of China's integrated strategy elements: political commitment, financing, research, zoonotic approach, and accountability.

Main Results:

• China met its goal of a 20% TB incidence reduction between 2015 and 2024.
• China has established clear national and provincial TB incidence-reduction targets for 2025 and 2030.
• China's strategy integrates political will, scientific rigor, sustainable funding, innovation, a dual TB approach, and accountability.

Conclusions:

• China's science-driven, strategic transformation offers a successful model for TB control.
• The Chinese approach provides a practical implementation pathway for global TB elimination efforts.
• This strategy can help revitalize global TB combat initiatives and restore confidence in achieving TB elimination.